Navigation Links
Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease
Date:7/3/2008

www.medivation.com" target="_new">http://www.medivation.com.

This press release contains forward-looking statements, including statements regarding anticipated clinical and regulatory milestones, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties that could cause actual results to differ significantly from those projected. You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. None of the Company's product candidates has been approved for sale, significant additional animal and human testing is required in order to seek marketing approval for any of its product candidates, and Medivation cannot assure you that marketing approval can be obtained for any of its product candidates. Furthermore, as is typically the case at this stage of the regulatory review process, the FDA has not yet performed an in-depth review of Medivation's preclinical and clinical data, so its views remain subject to change. Medivation's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-KSB for the year ended December 31, 2007 and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2008, include information about additional factors that could affect the Company's financial and operating results.


'/>"/>
SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
2. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
3. Medivations Dimebon(TM) Significantly Improved Daily Function in Alzheimers Disease Patients, Resulting in Reduced Need for Caregiver Assistance
4. Medivations Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year
5. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
6. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting
7. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
8. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
11. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... BASKING RIDGE, N.J. , Oct. 22, 2014 ... (RMANJ), a world-renowned leader in the field ... more rapid approach to embryonic screening. The research ... American Society for Reproductive Medicine (ASRM) meeting in ... chromosome screening (CCS) and single gene defect (SGD) ...
(Date:10/22/2014)... AVACEN Medical announced today that its AVACEN ... clearance by the U.S. Food and Drug Administration. This ... the Internet for: the temporary relief of joint ... and sprains . Logo - http://photos.prnewswire.com/prnh/20141021/153513 ... is a sophisticated medical device incorporating over 3,000 firmware ...
(Date:10/22/2014)... 22, 2014  With a vision to ensure ... a Global Pharmaceutical and Biotech manufacturer selects and ... turnkey solution to protect their animal health brand.  ... Photo - http://photos.prnewswire.com/prnh/20141021/153439 ... and aggregated by the Xyntek and Antares solution ...
Breaking Medicine Technology:New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 3AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode 2Xyntek and Antares Serialization Solution Protects Pets Too! 2
... MIAMI, Jan. 23, 2012  (OTC: IFIX) Internal Fixation Systems ... the FDA to market subtalar implants. These implants are ... to treat both trauma conditions and arthritis.  IFS CEO, ... to continue to fill out our portfolio, and gives ...
... 23, 2012  Virtify, Inc., will host an online roundtable ... open discussion by senior executives from four multinational pharmaceutical ... taking to comply with the July 2, 2012 EVMPD ... (Logo: http://photos.prnewswire.com/prnh/20110131/NE38689LOGO ) Roundtable ...
Cached Medicine Technology:Internal Fixation Systems Announces 510(k) Approval Granted by FDA for Subtalar Implants 2Roundtable of Industry Experts to Discuss Impact, Implications of EVMPD Mandate 2
(Date:10/25/2014)... Mesothelioma researchers are reporting extended survival ... (Alimta), after his combination drug therapy became too toxic. ... just posted on the Surviving Mesothelioma website. , ... in Japan suggests that “maintenance therapy” with pemetrexed may ... cannot tolerate higher doses of cisplatin. , “Although ...
(Date:10/25/2014)... FRIDAY, Oct. 24, 2014 (HealthDay News) -- Not getting ... of ulcerative colitis, a new study suggests. Those ... to eight hours per night may be more prone ... the intestines, researchers report. The study authors concluded that ... be considered among patients with inflammatory bowel diseases. ...
(Date:10/25/2014)... Dotinga HealthDay Reporter FRIDAY, ... are developed that spot increased risks for certain cancers, one ... getting screened. But a new study suggests that, at ... who found out their genes doubled their risk of colon ... to get screened. "It didn,t make any difference, not ...
(Date:10/22/2014)... On October 22, CBS will air an episode ... fictional and real. The Charles E Holman Morgellons ... advocacy and philanthropy in the battle against Morgellons Disease, ... impart truth and clarity about this misunderstood and routinely ... about Morgellons Disease (MD) and most people ...
(Date:10/22/2014)... Norton HealthDay Reporter , TUESDAY, ... the three Ebola cases in Dallas. But, mental health specialists ... Americans. President Barack Obama on Friday appointed an Ebola ... has infected two Dallas nurses who cared for a Liberian ... Presbyterian Hospital. But the U.S. cases are miniscule in ...
Breaking Medicine News(10 mins):Health News:New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma 2Health News:Sleep Duration Linked to Ulcerative Colitis Risk in Study 2Health News:Knowing Genetic Risk for Cancer May Not Change Behavior 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3
... , WELLESLEY HILLS, Mass., Sept. 1 Joseph ... Gastrointestinal Early Development Candidate Program will be part of the ... auction. , , The P2Y2, an ... agonist for treatment of constipation. , , ...
... , WASHINGTON, Sept. 1 , , WHAT: Chronic viral hepatitis ... cirrhosis that costs the nation,s health system hundreds of, ... attention. As many as 2 million people in the United States are, ... chronically infected with hepatitis C. However, most do ...
... suggests students should be wary when walking around parking ... -- Here,s some disturbing research to kick off the ... every six drivers near schools is distracted. , A ... phones, grooming, drinking, eating, smoking and even reading -- ...
... , , , ... member hospitals and suppliers to enable the healthcare industry to utilize ... Location Number (GLN), in transactions through the GHX exchange, which is ... of the standard. With guidance from members of the GHX industry ...
... NEW YORK, Sept. 1 Green parenting -- more than ... babies with lasting results. Parents today feel overwhelmed by all the choices ... Organic Guide to Baby,s First 24 Months (HarperPaperbacks: September ... why "going green" is universally the best way to protect baby from ...
... a Critical Time , , ATLANTA, Sept. 1 ... historical turning point. The country is now embroiled in ... massive for medical device, diagnostic, biopharmaceutical, healthcare information system, ... and investors. , At this critical junction and in ...
Cached Medicine News:Health News:EPIX Pharmaceuticals, Inc. Announces the P2Y2 Gastrointestinal Early Development Candidate Program Will Be Part of the Intellectual Property Offered For Sale at the September 30, 2009 Auction 2Health News:National Summit on Viral Hepatitis to be Held September 10-11 in Washington, D.C. 2Health News:National Summit on Viral Hepatitis to be Held September 10-11 in Washington, D.C. 3Health News:Drivers Distracted When Near Schools 2Health News:GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with GLN Sunrise Date 2Health News:GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with GLN Sunrise Date 3Health News:GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with GLN Sunrise Date 4Health News:Green Parenting is Best for Baby's Health and Happiness While Much Easier and Affordable Than Many Parents Know 2Health News:Green Parenting is Best for Baby's Health and Happiness While Much Easier and Affordable Than Many Parents Know 3Health News:7th Annual Healthcare M A and Business Development Conference, September 9-10, 2009, Atlanta, GA 2
... 2 O W/O Adapter., ... humidifier systems feature a dual-purpose reservoir with a ... secure attachment of a humidifier adapter. The oxygen ... reaching oxygen delivery tubing. An audible relief valve ...
... EMPTY W/AIR ENT 35%-100% FIO2, ,Empty ... 35% to 100%. It has ports for ... ,Empty Nebulizers 5007P and 5207 have ... , ,Convenient slip-on heaters are also ...
... , One device provides ... therapy from a single gas source ... decreasing the number of SKUs dedicated ... and inconvenience of double or wye ...
MISTY OX® Hi-Fi Nebulizer...
Medicine Products: